SMC recommends new type 2 diabetes drug

The Scottish Medicines Consortium (SMC) have given a positive recommendation for Invokana (canagliflozin), a new treatment option licensed for adults with type 2 diabetes, for whom diet and lifestyle measures or treatment with other blood sugar (glucose)-lowering medicines do not provide adequate control of their blood sugar levels.  This means that canagliflozin will now be available for prescription through NHS Scotland. “Type 2 diabetes is one of the most significant health challenges facing Scotland today,” commented Professor Miles Fisher, Consultant Physician, Glasgow Royal Infirmary, and Honorary Professor, University of Glasgow. “Gaining access to new treatments like canagliflozin, is important in